Manufacturing in Nigeria
Building regional capacity for a self-sustaining future
10000000
next-generation mosquito nets
will be produced every year, helping to close supply gaps and ensure timely access to cutting-edge malaria protection in Nigeria and across the region.
600 +
jobs in Nigeria
will be created in manufacturing, quality control and logistics, strengthening Nigeria's health sector and contributing to broader economic development.
SNG Health: a Nigerian hub for regional manufacturing
Together with our partner Harvestfield Industries, and with the support of the government of Nigeria, we have embarked on a first-of-its-kind joint venture to transform malaria prevention and strengthen health security through direct investment in mosquito net manufacturing in Nigeria. The new joint venture, named SNG Health, will manufacture PermaNet® Dual, our latest, dual active-ingredient pyrethroid-chlorfenapyr net designed to combat insecticide resistance.
SNG Health will commence operations in April 2026. The facility will meet rigorous international standards for product quality, insecticidal efficacy, and environmental sustainability.
This initiative is grounded in long-term collaboration with the Nigerian Ministry of Health, technical experts, and private sector partners—all committed to strengthening supply chains and building local capacity.
Every mosquito net produced here represents a Nigerian job, a Nigerian skill strengthened, and value created within our economy. This joint venture between Vestergaard and Harvestfield shows what responsible, future-focused partnership looks like.
We believe that responsible enterprise must support African leadership in health by investing in local systems, training professionals and strengthening the capacity needed for countries to have the autonomy to protect the health of their own people.
Vestergaard and Harvestfield break ground on landmark Ogun State, Nigeria facility to boost malaria prevention with cutting-edge mosquito net production
Producing health commodities where they will be used
70% of public health commodities in Africa are imported. But when it comes to malaria, Africa is where health commodities are most needed: Africa accounts for 95% of global malaria cases, with Nigeria alone bearing nearly a quarter of that burden.
As African countries build towards a self-sustaining future, new approaches are needed to boost access to tried-and-tested, cost-effective tools to combat the disease. Regional manufacturing of mosquito nets, medicines and vaccines is a priority for the continent.
Producing health commodities locally has multiple benefits, from bolstering regional supply chain resilience to strengthening public health infrastructure and increasing access to life-saving products. It also protects against the risk of future health service disruptions due to global shocks, such as the COVID-19 pandemic.